Form 4: NeuroMetrix CFO Reports Disposal of Shares and Restricted Stock Units Following Merger with electroCore

Thomas T. Higgins, CFO of NeuroMetrix, reports the disposal of common stock and restricted stock units due to the merger with electroCore, Inc.

Summary

• Thomas T. Higgins, the Senior Vice President and CFO of NeuroMetrix, Inc., filed a Form 4 on May 5, 2025, reporting changes in beneficial ownership of securities.
• The report details the disposal of common stock and restricted stock units (RSUs) following the merger between NeuroMetrix and electroCore, Inc.
• The merger, effective May 1, 2025, resulted in NeuroMetrix's common stock being converted into the right to receive cash and contingent value rights (CVRs).
• Specifically, 11,840 shares of common stock were disposed of.
• Additionally, 3,308 restricted stock units were converted into the right to receive cash and CVRs.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a merger. It doesn't inherently convey positive or negative sentiment, but rather reports factual transactions.

Future Outlook

The document outlines the immediate impact of the merger on the reporting person's holdings, with future value dependent on the terms of the contingent value rights agreement.

Industry Context

This announcement reflects a merger and acquisition activity within the medical technology sector, where companies often combine to leverage synergies, expand market reach, or acquire new technologies.

Key Dates

Keywords

Form 4, Merger, NeuroMetrix, electroCore, Higgins, Beneficial Ownership, Securities, Disposal, Common Stock, Restricted Stock Units, CVR